This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Severe Asthma: Clinical Phenotypes and the Emerging Age of Personalized Therapy

Severe Asthma: Clinical Phenotypes and the Emerging Age of Personalized Therapy

Format

Patient Case Simulations

Time to Complete

2.5 hours

Released

June 30, 2017

Expires

August 31, 2018
Add to Queue


Maximum Credits

2.50 / AMA PRA Category 1 CreditsTM

Note: In order to earn the full 2.50 credits, you must complete both of the following activities:
RME Hot Seat: 1.00 / AMA PRA Category 1 CreditTM
Virtual Practice: 1.50 / AMA PRA Category 1 CreditTM

Accredited Provider

These CME-certified enduring activities are jointly provided by

Commercial Supporter

Support for these activities has been provided through an educational grant from AstraZeneca.

Program Description

The FDA’s approval of several new tailored biologic therapies offers promise to a subset of patients with severe asthma, though identifying the asthma phenotypes (ie, eosinophilic and noneosinophilic) for which these new agents are most appropriate remains a key factor of their successful use.

This CME curriculum provides two dynamic e-learning activities that discuss the effective use of the newest biologic drugs and address key aspects of successfully assessing and treating patients with severe asthma.

Visit the Staff Conference room to participate in RME Hot Seat, an interactive Q&A where our expert faculty reviews the most recent evidence and provides answers to challenging clinical questions on the risks of asthma exacerbations, how to incorporate the newest asthma drugs for severe asthma, and current best practices for managing patients with severe asthma. Faculty slides are also included as printable/downloadable resources.

Visit the Exam Rooms or the Main Conference Room to participate in the three-module Virtual Practice. Every room (module) you visit confronts you with challenging clinical scenarios involving patients with severe asthma, similar to those you are likely to encounter in your own practice.

  • Clinical Callout (Main Conference Room): Here you’ll find four patient vignettes that end at a critical clinical decision point. Your challenge: assess the symptoms, risk factors, and medical histories and choose the most appropriate next step from several possible clinical strategies. But be careful: only one option reflects current best practice!
  • Exam Room 1: Margaret Thomas, 40, has had asthma for 10 years, but her symptoms have worsened recently and she has experienced two serious exacerbations. Was it a change in her medications? Is it related to her allergies?
  • Exam Room 2: Al Carter, 55, was first diagnosed with asthma 15 years ago. In the last 3 months, his asthma has been uncontrolled despite the use of oral corticosteroids, and he was hospitalized. Are adjustments needed to Al’s regimen? If so, what are they?
  • Resource Library: Offers downloadable content discussed in the Virtual Practice.

Intended Audience

These activities have been designed to meet the educational needs of allergists, immunologists, pulmonologists, and primary care providers—including nurse practitioners and physician assistants—who are involved in the treatment of patients with severe asthma.

Educational Objectives

Upon completion of this activity, participants should be able to:

  • List the clinical characteristics of the various phenotypes of severe asthma
  • Discuss the most recent Global Initiative for Asthma (GINA) guidelines for severe asthma treatment (Steps 4/5)
  • Outline a personalized treatment plan, using targeted biologic therapies, to achieve and maintain control for patients with severe asthma based on underlying phenotype
  • Demonstrate how incorporating patient education and communication strategies can improve medication adherence and asthma control

Faculty

Bradley E. Chipps, MD (Program Chair)
Medical Director
Capital Allergy & Respiratory Disease Center
Sacramento, CA

Stephen P. Peters, MD, PhD
Thomas H. Davis Chair in Pulmonary Medicine
Chief, Section on Pulmonary, Critical Care, Allergy & Immunologic Diseases
Professor of Internal Medicine, Pediatrics, and Translational Science
Wake Forest School of Medicine
Executive Director, Respiratory Service Line, Wake Forest Baptist Health
Winston-Salem, NC

Michael E. Wechsler, MD, MMSc
Co-Director
Cohen Family Asthma Institute
Professor of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health
Denver, CO

Instructions

Clicking "START ACTIVITY" will send you away from myCME to our partner site, RedMedEd. Full accreditation/designation and disclosure information will be provided on the RedMedEd site.

There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive CME credit for participation, participants must complete the post-tests (achieving a passing grade of 75% or greater) and program evaluation. Certificates can be printed immediately and will not be stored in your myCME CME History.

For technical questions related to this activity, please contact RedMedEd at (610) 251-6841 or info@redmeded.com.

For questions regarding the activity content, or CME-related questions or concerns, contact RBHS at (973) 972-4267 or ccoe@ca.rutgers.edu.

Hardware/Software Requirements

  • Apple iPad or iPad mini (iOS 8 or higher) with an Internet connection
  • A computer with an Internet connection
    • Internet browser: Google Chrome, Internet Explorer 9 or higher, Firefox 26 or higher, or Safari 5 or higher
    • Additional software: Adobe Flash Player and/or an HTML 5-capable browser is required for video or audio playback; Adobe Acrobat Reader may occasionally be required
Add to Queue